EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 18th, 2015 • Teladoc, Inc. • Services-offices & clinics of doctors of medicine • New York
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of June 17, 2015, by and between Teladoc, Inc., a Delaware corporation (the “Company”), and Michael King (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), and will become effective on the closing of the Company’s initial public offering of common stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 18th, 2015 • Teladoc, Inc. • Services-offices & clinics of doctors of medicine • New York
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of June 17, 2015, by and between Teladoc, Inc., a Delaware corporation (the “Company”) and Mark Hirschhorn (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), and will become effective on the closing of the Company’s initial public offering of common stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 18th, 2015 • Teladoc, Inc. • Services-offices & clinics of doctors of medicine • New York
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of June 16, 2015, by and between Teladoc, Inc., a Delaware corporation (the “Company”), and Jason Gorevic, an individual resident of the State of New York (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”) and will become effective on the closing of the Company’s initial public offering of common stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).